A successful Ebola vaccine delivery shows how a COVID-19 vaccine would work in Africa
“The Ebola vaccine developed by Merck also used ultra-cold equipment of about -70 oC and we were able to deploy that vaccine in the Democratic Republic of Congo to respond to the North Kivu outbreak where more than 300,000 people were immunized.”